Literature DB >> 26862492

Overview, prevention and management of chemotherapy extravasation.

Firas Y Kreidieh1, Hiba A Moukadem1, Nagi S El Saghir1.   

Abstract

Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation and latest advances in definitions, classification, prevention, management and guidelines. We review the grading of extravasation and tissue damage according to various chemotherapeutic drugs and present an update on treatment and new antidotes including dexrazoxane for anthracyclines extravasation. We highlight the importance of education and training of the oncology team for prevention and prompt pharmacological and non-pharmacological management and stress the availability of new antidotes like dexrazoxane wherever anthracyclines are being infused.

Entities:  

Keywords:  Antidote; Chemotherapy; Dexrazoxane; Dimethyl sulfoxide; Extravasation; Hyaluronidase; Tissue damage; Vesicant

Year:  2016        PMID: 26862492      PMCID: PMC4734939          DOI: 10.5306/wjco.v7.i1.87

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  51 in total

Review 1.  Hyperbaric oxygen: its uses, mechanisms of action and outcomes.

Authors:  A L Gill; C N A Bell
Journal:  QJM       Date:  2004-07

2.  Extravasation injuries: implications for WOC nursing.

Authors:  Kathy Froiland
Journal:  J Wound Ostomy Continence Nurs       Date:  2007 May-Jun       Impact factor: 1.741

Review 3.  Infiltration and extravasation: update on prevention and management.

Authors:  Darcy Doellman; Lynn Hadaway; Leigh Ann Bowe-Geddes; Michelle Franklin; Jack LeDonne; Lorelei Papke-O'Donnell; Janet Pettit; Lisa Schulmeister; Marc Stranz
Journal:  J Infus Nurs       Date:  2009 Jul-Aug

Review 4.  Advances in nano drugs for cancer chemotherapy.

Authors:  Imran Ali; K Salim; Mohmad A Rather; Waseem A Wani; Ashanul Haque
Journal:  Curr Cancer Drug Targets       Date:  2011-02       Impact factor: 3.428

5.  European Oncology Nursing Society extravasation guidelines.

Authors:  Y Wengström; A Margulies
Journal:  Eur J Oncol Nurs       Date:  2008-09       Impact factor: 2.398

Review 6.  Management of extravasation injuries: a focused evaluation of noncytotoxic medications.

Authors:  Paul M Reynolds; Robert MacLaren; Scott W Mueller; Douglas N Fish; Tyree H Kiser
Journal:  Pharmacotherapy       Date:  2014-01-13       Impact factor: 4.705

Review 7.  A review of clinical experience with paclitaxel extravasations.

Authors:  Brad L Stanford; Fred Hardwicke
Journal:  Support Care Cancer       Date:  2003-03-27       Impact factor: 3.603

8.  Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report.

Authors:  Pei-Hung Chang; Mei-Ti Wang; Yi-Hua Chen; Yu-Ying Chen; Cheng-Hsu Wang
Journal:  Oncol Lett       Date:  2014-02-27       Impact factor: 2.967

Review 9.  Anthracycline extravasation: a comprehensive review of experimental and clinical treatments.

Authors:  Seppo W Langer; Maxwell Sehested; Peter Buhl Jensen
Journal:  Tumori       Date:  2009 May-Jun

Review 10.  Dexrazoxane for the treatment of chemotherapy-related side effects.

Authors:  Seppo W Langer
Journal:  Cancer Manag Res       Date:  2014-09-15       Impact factor: 3.989

View more
  27 in total

1.  Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing.

Authors:  Anh-Vu Do; Sean M Geary; Dongrim Seol; Philip Tobias; Daniel Carlsen; Nattawut Leelakanok; James A Martin; Aliasger K Salem
Journal:  Int J Pharm       Date:  2018-01-17       Impact factor: 5.875

2.  Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes.

Authors:  Kazuhiro Nishiyama; Takuro Numaga-Tomita; Yasuyuki Fujimoto; Tomohiro Tanaka; Chiemi Toyama; Akiyuki Nishimura; Tomohiro Yamashita; Naoya Matsunaga; Satoru Koyanagi; Yasu-Taka Azuma; Yuko Ibuki; Koji Uchida; Shigehiro Ohdo; Motohiro Nishida
Journal:  Br J Pharmacol       Date:  2019-08-06       Impact factor: 8.739

Review 3.  Adult oncology patients' experiences of living with a central venous catheter: a systematic review and meta-synthesis.

Authors:  Dhurata Ivziku; Raffaella Gualandi; Francesca Pesce; Anna De Benedictis; Daniela Tartaglini
Journal:  Support Care Cancer       Date:  2022-01-14       Impact factor: 3.603

4.  Cervical dissecting extravasation of oxaliplatin: A case report.

Authors:  Jorge Hernando; Judit Riera-Arnau; Maria Roca; Alejandro Garcia; Jaume Capdevila
Journal:  Mol Clin Oncol       Date:  2022-01-12

Review 5.  Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer.

Authors:  René J Boosman; Jacobus A Burgers; Egbert F Smit; Neeltje Steeghs; Anthonie J van der Wekken; Jos H Beijnen; Alwin D R Huitema; Rob Ter Heine
Journal:  Drugs       Date:  2021-12-11       Impact factor: 9.546

6.  Regimen of 5-Fluorouracil and Cisplatin Increases the Incidence of Extravasation in Patients Undergoing Chemotherapy.

Authors:  Hisashi Tagashira; Yasuhisa Izushi; Tomoki Ikuta; Yasumasa Koike; Yoshihisa Kitamura; Hiroshi Yamamoto
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 7.  Ambulatory chemotherapy: Past, present, and future.

Authors:  Racha Sabbagh Dit Hawasli; Stephen Barton; Shereen Nabhani-Gebara
Journal:  J Oncol Pharm Pract       Date:  2021-01-18       Impact factor: 1.809

8.  A decision process for drug discovery in retinoblastoma.

Authors:  María Belen Cancela; Santiago Zugbi; Ursula Winter; Ana Laura Martinez; Claudia Sampor; Mariana Sgroi; Jasmine H Francis; Ralph Garippa; David H Abramson; Guillermo Chantada; Paula Schaiquevich
Journal:  Invest New Drugs       Date:  2020-11-16       Impact factor: 3.850

9.  Efficacy of combination of localized closure, ethacridine lactate dressing, and phototherapy in treatment of severe extravasation injuries: A case series.

Authors:  Yan-Xu Lu; Ying Wu; Peng-Fei Liang; Rong-Chan Wu; Ling-Yun Tian; Hui-Ying Mo
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

10.  Outcomes and Management of Peripheral Intravenous Infiltration Injuries.

Authors:  Joseph T Gibian; Danny Zakria; Cooper March; Basil Schaheen; Brian C Drolet
Journal:  Hand (N Y)       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.